BRANCHINI, Alessio
BRANCHINI, Alessio
Dipartimento di Scienze della vita e biotecnologie
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects
file con accesso da definire2023 Pedriali, G.; Ramaccini, D.; Bouhamida, E.; Branchini, A.; Turrin, G.; Tonet, E.; Scala, A.; Patergnani, S.; Pinotti, M.; Trapella, C.; Giorgi, C.; Tremoli, E.; Campo, G.; Morciano, G.; Pinton, P.
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia
file con accesso da definire2022 Tonetto, E.; Tarantino, R.; Testa, M. F.; Peretto, L.; Bernardi, F.; Pinotti, M.; Branchini, A.
A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms
file con accesso da definire2022 M. Sacco, M. Tardugno; De Cristofaro, R.; Lancellotti, S.; Bernardi, F.; Pinotti, M.; Branchini, A.; Giusti, B.; Castaman, G.
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia
2020 Branchini, Alessio; Ferrarese, Mattia; Nilsen, Jeannette; Bern, Malin; Davidson, Robert J.; Camire, Rodney M.; Roopenian, Derry C.; Sandlie, Inger; Lombardi, Silvia; Terje Andersen, Jan; Pinotti, Mirko
A recoded view on the F9 p.Cys178Ter pathogenic mechanism
2020 Branchini, A.; Pinotti, M.
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B
2018 Pignani, Silvia; Todaro, Alice; Ferrarese, Mattia; Marchi, Saverio; Lombardi, Silvia; Balestra, Dario; Pinton, Paolo; Bernardi, Francesco; Pinotti, Mirko; Branchini, Alessio
Academic Editor per la rivista PLoS One
file con accesso da definire2020 Branchini, Alessio
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study
2016 Martinelli, N; Girelli, D; Baroni, Marcello; Guarini, P; Sandri, M; Lunghi, Barbara; Tosi, F; Branchini, Alessio; Sartori, F; Woodhams, B; Bernardi, Francesco; Olivieri, O.
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction
file con accesso da definire2013 F., Tosi; N., Martinelli; Baroni, Marcello; P., Guarini; S., Udali; Branchini, Alessio; B., Woodhams; Bernardi, Francesco; O., Olivieri
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant
file con accesso da definire2012 Cavallari, Nicola; Balestra, Dario; Branchini, Alessio; Maestri, Iva; Chuamsunrit, A; Sasanakul, W; Mariani, G; Pagani, F; Bernardi, Francesco; Pinotti, Mirko
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth
2019 Marchi, Saverio; Corricelli, Mariangela; Branchini, Alessio; Vitto, VERONICA ANGELA MARIA; Missiroli, Sonia; Morciano, Giampaolo; Perrone, Mariasole; Ferrarese, Mattia; Giorgi, Carlotta; Pinotti, Mirko; Galluzzi, Lorenzo; Kroemer, Guido; Pinton, Paolo
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A
2019 Balestra, Dario; Maestri, Iva; Branchini, Alessio; Ferrarese, Mattia; Bernardi, Francesco; Pinotti, Mirko
An engineered factor X variant as a novel by-passing agent for hemophilia
file con accesso da definire2022 Tonetto, Elena; Testa, Maria Francesca; Tarantino, Rebecca; Peretto, Laura; Pinotti, Mirko; Branchini, Alessio
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics
2020 Bern, M.; Nilsen, J.; Ferrarese, M.; Sand, K. M. K.; Gjolberg, T. T.; Lode, H. E.; Davidson, R. J.; Camire, R. M.; Baekkevold, E. S.; Foss, S.; Grevys, A.; Dalhus, B.; Wilson, J.; Hoydahl, L. S.; Christianson, G. J.; Roopenian, D. C.; Schlothauer, T.; Michaelsen, T. E.; Moe, M. C.; Lombardi, S.; Pinotti, M.; Sandlie, I.; Branchini, A.; Andersen, J. T.
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes
2016 Barbon, Elena; Pignani, Silvia; Branchini, Alessio; Bernardi, Francesco; Pinotti, Mirko; Bovolenta, Matteo
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency
2020 Balestra, D.; Ferrarese, M.; Lombardi, S.; Ziliotto, N.; Branchini, A.; Petersen, N.; Bosma, P.; Pinotti, M.; van de Graaf, S. F. J.
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough
2017 Branchini, Alessio; Ferrarese, Mattia; Castaman, Giancarlo; Bernardi, Francesco; Pinotti, Mirko
Associate Editor per la rivista Frontiers in Genetics - sezione Genetic Disorders
file con accesso da definire2020 Branchini, Alessio
Associate Editor per la rivista Frontiers in Pediatrics - sezione Genetic Disorders
file con accesso da definire2020 Branchini, Alessio
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype
file con accesso da definire2010 Branchini, Alessio; Rizzotto, Lara; Giansily Blaizot, M.; Canella, Alessandro; Mari, R.; Lapecorella, M.; Napolitano, M.; Mariani, G.; Pinotti, Mirko; Bernardi, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects | 2023 | Pedriali, G.; Ramaccini, D.; Bouhamida, E.; Branchini, A.; Turrin, G.; Tonet, E.; Scala, A.; Pate...rgnani, S.; Pinotti, M.; Trapella, C.; Giorgi, C.; Tremoli, E.; Campo, G.; Morciano, G.; Pinton, P. | file con accesso da definire |
| A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia | 2022 | Tonetto, E.; Tarantino, R.; Testa, M. F.; Peretto, L.; Bernardi, F.; Pinotti, M.; Branchini, A. | file con accesso da definire |
| A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms | 2022 | M. Sacco, M. Tardugno; De Cristofaro, R.; Lancellotti, S.; Bernardi, F.; Pinotti, M.; Branchini, ...A.; Giusti, B.; Castaman, G. | file con accesso da definire |
| A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia | 2020 | Branchini, Alessio; Ferrarese, Mattia; Nilsen, Jeannette; Bern, Malin; Davidson, Robert J.; Camir...e, Rodney M.; Roopenian, Derry C.; Sandlie, Inger; Lombardi, Silvia; Terje Andersen, Jan; Pinotti, Mirko | |
| A recoded view on the F9 p.Cys178Ter pathogenic mechanism | 2020 | Branchini, A.; Pinotti, M. | |
| A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B | 2018 | Pignani, Silvia; Todaro, Alice; Ferrarese, Mattia; Marchi, Saverio; Lombardi, Silvia; Balestra, D...ario; Pinton, Paolo; Bernardi, Francesco; Pinotti, Mirko; Branchini, Alessio | |
| Academic Editor per la rivista PLoS One | 2020 | Branchini, Alessio | file con accesso da definire |
| Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study | 2016 | Martinelli, N; Girelli, D; Baroni, Marcello; Guarini, P; Sandri, M; Lunghi, Barbara; Tosi, F; Bra...nchini, Alessio; Sartori, F; Woodhams, B; Bernardi, Francesco; Olivieri, O. | |
| Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction | 2013 | F., Tosi; N., Martinelli; Baroni, Marcello; P., Guarini; S., Udali; Branchini, Alessio; B., Woodh...ams; Bernardi, Francesco; O., Olivieri | file con accesso da definire |
| Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant | 2012 | Cavallari, Nicola; Balestra, Dario; Branchini, Alessio; Maestri, Iva; Chuamsunrit, A; Sasanakul, ...W; Mariani, G; Pagani, F; Bernardi, Francesco; Pinotti, Mirko | file con accesso da definire |
| Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth | 2019 | Marchi, Saverio; Corricelli, Mariangela; Branchini, Alessio; Vitto, VERONICA ANGELA MARIA; Missir...oli, Sonia; Morciano, Giampaolo; Perrone, Mariasole; Ferrarese, Mattia; Giorgi, Carlotta; Pinotti, Mirko; Galluzzi, Lorenzo; Kroemer, Guido; Pinton, Paolo | |
| An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A | 2019 | Balestra, Dario; Maestri, Iva; Branchini, Alessio; Ferrarese, Mattia; Bernardi, Francesco; Pinott...i, Mirko | |
| An engineered factor X variant as a novel by-passing agent for hemophilia | 2022 | Tonetto, Elena; Testa, Maria Francesca; Tarantino, Rebecca; Peretto, Laura; Pinotti, Mirko; Branc...hini, Alessio | file con accesso da definire |
| An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics | 2020 | Bern, M.; Nilsen, J.; Ferrarese, M.; Sand, K. M. K.; Gjolberg, T. T.; Lode, H. E.; Davidson, R. J....; Camire, R. M.; Baekkevold, E. S.; Foss, S.; Grevys, A.; Dalhus, B.; Wilson, J.; Hoydahl, L. S.; Christianson, G. J.; Roopenian, D. C.; Schlothauer, T.; Michaelsen, T. E.; Moe, M. C.; Lombardi, S.; Pinotti, M.; Sandlie, I.; Branchini, A.; Andersen, J. T. | |
| An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes | 2016 | Barbon, Elena; Pignani, Silvia; Branchini, Alessio; Bernardi, Francesco; Pinotti, Mirko; Bovolent...a, Matteo | |
| An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency | 2020 | Balestra, D.; Ferrarese, M.; Lombardi, S.; Ziliotto, N.; Branchini, A.; Petersen, N.; Bosma, P.; ...Pinotti, M.; van de Graaf, S. F. J. | |
| An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough | 2017 | Branchini, Alessio; Ferrarese, Mattia; Castaman, Giancarlo; Bernardi, Francesco; Pinotti, Mirko | |
| Associate Editor per la rivista Frontiers in Genetics - sezione Genetic Disorders | 2020 | Branchini, Alessio | file con accesso da definire |
| Associate Editor per la rivista Frontiers in Pediatrics - sezione Genetic Disorders | 2020 | Branchini, Alessio | file con accesso da definire |
| Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype | 2010 | Branchini, Alessio; Rizzotto, Lara; Giansily Blaizot, M.; Canella, Alessandro; Mari, R.; Lapecore...lla, M.; Napolitano, M.; Mariani, G.; Pinotti, Mirko; Bernardi, Francesco | file con accesso da definire |